Skin tumor risk among atomic-bomb survivors in Japan

Cancer Causes & Control - Tập 9 - Trang 393-401 - 1998
Elaine Ron1, Dale L. Preston2, Kiyohiko Mabuchi3, Shoji Tokuoka4, Masao Kishikawa5, Masachika Iseki6, Toshihiro Kobuke7, Masayoshi Tokunaga8
1Radiation Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA
2Department of Statistics, Institute for Developmental Research, Aichi Human Service Center, Aichi Prefectural Colony, Japan
3Department of Epidemiology, Institute for Developmental Research, Aichi Human Service Center, Aichi Prefectural Colony, Japan
4Consultant at the Radiation Effects Research Foundation (RERF), Hiroshima, Japan
5Department of Morphology, Institute for Developmental Research, Aichi Human Service Center, Aichi Prefectural Colony, Japan
6Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
7Research Laboratory, Welfare Association Onomichi General Hospital, Onomichi, Japan
8Department of Public Health and Division of Persistent Oncogenic Viruses, Center of Shronic Viral Diseases, Kagoshima University School of Medicine, Kagoshima, Japan

Tóm tắt

Objectives: Elevated risks of skin cancer following high doses of ionizing radiation have long been known. Recent reports on atomic-bomb survivors indicate that nonmelanoma skin cancer can be induced at low to medium doses. We studied atomic-bomb survivors to determine the effects of radiation on specific histologic types of skin cancer and to describe the dose-response relationship. Methods: Cases of melanoma, nonmelanoma skin cancers, and Bowen's disease were ascertained between 1958 and 1987 for the 80,000 cohort members through the population-based Hiroshima and Nagasaki (Japan) tumor registries augmented by searches of other records. Results: An excess of basal cell carcinoma (n=80), with some suggestion of a non-linear dose-response, was observed. The excess risk decreased markedly as age at exposure increased, and there was no evidence for an interaction between ionizing and ultraviolet radiation. No dose-response was found for squamous cell carcinoma (n=69). The excess relative risk point-estimates were large, but statistically nonsignificant for both melanoma (n=10) and Bowen's disease (n=26). Conclusions: The basal layer of the epidermis appears to be quite sensitive to radiation carcinogenesis, particularly at a young age. The suprabasal layer seems to be more resistant, as shown by the lack of an association for squamous cell carcinomas.

Tài liệu tham khảo

Johnson MLT, Land CE, Gregory PB, Taura T, Milton, RC. Effects of Ionizing Radiation on the Skin, Hiroshima and Nagasaki. Hiroshima, Japan: Radiation Effects Research Foundation, 1969; RERF Technical Report Series TR 20-69. Sadamori N, Otake M, Honda T. Study of Skin Cancer Incidence in Nagasaki Atomic Bomb Survivors, 1958-85. Hiroshima, Japan: Radiation Effects Research Foundation, 1991; RERF Technical Report Series TR 10-91. Sadamori N, Mine M, Hori M. Skin cancer among atomic bomb survivors [Letter]. Lancet 1989; 1: 1267. Sadamori N, Mine M, Honda T. Incidence of skin cancer among Nagasaki atomic bomb survivors. J Radiat Res 1991; 32(Suppl 2): 217–25. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 1994; 137: S17–S67 [based on RERF TR 5-92]. Little MP, Charles MW. The risk of non-melanoma skin cancer incidence in the Japanese atomic bomb survivors. Int J Radiat Biol 1997; 71: 589–602. Yamada M, Kodama K, Fujita S, et al. Prevalence of skin neoplasms among the atomic bomb survivors. Radiat Res 1996; 146: 223–6. Hildreth NG, Shore RE, Hempelmann LH, Rosenstein M. Risk of extrathyroid tumors following radiation treatment in infancy for thymic enlargement. Radiat Res 1985; 102: 378–91. Ron E, Modan B, Preston DL, Alfandary E, Stovall M, Boice JD Jr. Radiation-induced skin carcinomas of the head and neck. Radiat Res 1991; 125: 318–25. Shore RE. Overview of radiation-induced skin cancer in humans. Int J Radiat Biol 1990; 57: 809–27. Shore RE, Albert RE, Reed M, Harley N, Pasternack BS. Skin cancer incidence among children irradiated for ringworm of the scalp. Radiat Res 1984; 100: 192–204. Van Vloten WA, Hermans J, Van Daal WAJ. Radiationinduced skin cancer and radiodermatitis of the head and neck. Cancer 1987; 59: 411–4. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death (ICD-9). Geneva, Switzerland: World Health Organization, 1975. World Health Organization. International Histological Classification of Tumours. No. 12, Histological Typing of Skin Tumours. Geneva, Switzerland: World Health Organization, 1974. Roesch WC, ed. Final Report on the Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki. Hiroshima, Japan: Radiation Effects Research Foundation, 1987. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res 1990; 123: 275–84 [based on RERF TR 2-89]. Sposto R, Preston DL. Correcting for Catchment Area Nonresidency in Studies Based on Tumor-Registry Data. Hiroshima, Japan: Radiation Effects Research Foundation, 1992; RERF Commentary and Review Series CR 1-92. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol. 2. The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer, 1987; IARC Sci. Pub. No. 82. Cox DR, Hinckley DV. Theoretical Statistics. London,UK: Chapman and Hall, 1974. Preston DL, Lubin JH, Pierce DA. Epicure User’s Guide. Seattle, WA (USA): HiroSoft International Corporation, 1993. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents, Vol. VII. Lyon, France: International Agency for Research on Cancer, 1997; IARC Sci. Pub. No. 143. Mabuchi K, Soda M, Ron E, et al. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res 1994; 137:S1–S16. Scotto J, Fears TR, Kraemer KH, Fraumeni JF Jr. Nonmelanoma skin cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. New York, NY (USA): Oxford University Press, 1996: 1313–30. Gordon D, Silverstone H. Worldwide epidemiology of premalignant and malignant cutaneous lesions. In: Andrade R, Gumport S, Popkin G, Rees T, eds. Cancer of the Skin: Biology-Diagnosis-Management, Vol. I. Philadelphia, PA (USA): Saunders, 1976: 405–34 Karagas MR, McDonald JA, Greenberg ER, et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. J Natl Cancer Inst 1996; 88: 1848–53. Gallagher RP, Bajdik CD, Fincham S, et al. Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin. Cancer Epidemiol Biomark Prev 1996; 5: 419–24. 27. International Commission on Radiation Protection. The Biological Basis for Dose Limitation in the Skin. Oxford, UK: Pergamon Press, 1991; Publication 59, Annals of the ICRP 22 (2). Allen AC. Skin. In: Kissane JM, ed. Anderson’s Pathology. Vol. 2. 9th Ed. St. Louis, MO (USA): C.V. Mosby Company, 1990: 1751–800. Murphy GF, Elder DE. Atlas of Tumor Pathology. Nonmelanocytic Tumors of the Skin. Washington, DC (USA): Armed Forces Institute of Pathology, 1991: 11–60. Korczak JF, Brahim JS, DiGiovanna JJ, Kase RG, Wexler LH, Goldstein AM. Nevoid basal cell carcinoma syndrome with medulloblastoma in an African-American boy: A rare case illustrating gene-environment interaction. Am J Med Genet 1997; 69: 309–14. Sevcova M, Sevc J, Thomas J. Alpha irradiation of the skin and the possibility of late effects. Health Phys 1978; 35: 803–6.